According to our latest research, the global Secnidazole Tablets market size reached USD 665 million in 2025, reflecting robust demand driven by the increasing prevalence of protozoal infections and bacterial vaginosis worldwide. The market is expected to grow at a CAGR of 8.4% from 2026 to 2034, ultimately reaching a forecasted value of USD 1,348 million by 2034. The primary growth factor for the Secnidazole Tablets market is the rising incidence of sexually transmitted infections and gastrointestinal diseases, coupled with the expanding adoption of single-dose therapies for improved patient compliance. https://growthmarketreports.com/report/secnidazole-tablets-market